Trial Profile
Evaluation of the clinical usefulness of rupatadine in patients with seasonal allergic rhinitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 02 Apr 2018 Status changed from active, no longer recruiting to completed.
- 15 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Mar 2018 Status changed from not yet recruiting to recruiting.